𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells

✍ Scribed by M. Joan Allalunis-Turner; Rufus S. Day; John D. S. McKean; Kenneth C. Petruk; Peter B. R. Allen; Keith E. Aronyk; Bryce K. A. Weir; Debbie Huyser-Wierenga; Dorcas S. Fulton; R. C. Urtasun


Publisher
Springer US
Year
1991
Tongue
English
Weight
796 KB
Volume
11
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Cytotoxic effects of glutathione synthes
✍ Robert T. Dorr; James D. Liddil; Michelle J. Soble 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 601 KB

The glutathione (GSH) synthesis inhibitor, buthionine sulfoximine (BSO) was tested for cytotoxicity and thiol depletion in murine and human tumor cells in vitro, and for its antitumor activity and toxicity in vivo. The cell lines used in these studies included murine L-1210 leukemia, human RPMI 8226

Effect of buthionine sulfoximine on PtII
✍ Prakash Mistry; Swee Y. Loh; Lloyd R. Kelland; Ken R. Harrap 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 752 KB

## Abstract Glutathione (GSH) has often been implicated in the mechanism of resistance to platinum anti‐cancer drugs. It has been suggested that GSH may reduce the cytotoxicity of these drugs by forming inactive conjugates and by enhancing the repair of DNA‐platinum crosslinks. In the present study

Expression of antisense bcl-2 cDNA aboli
✍ Cong Ju Zhu; Yong Biao Li; Meng Cheong Wong 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Bcl‐2 is a key antiapoptotic protein, and it confers survival advantages on many types of tumors by inhibiting apoptotic cell death. Malignant gliomas are the most common primary central nervous system tumors, but the role of bcl‐2 in these tumors has not been defined. We investigated t

Growth-inhibitory and chemosensitizing e
✍ Evangelos Kogias; Nadja Osterberg; Brunhilde Baumer; Nikolaos Psarras; Christoph 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 955 KB

## Abstract Glutathione‐__S__‐transferases (GSTs) are upregulated in malignant gliomas and contribute to their chemoresistance. The nitric oxide (NO) donor PABA/NO (O^2^‐{2,4‐dinitro‐5‐[4‐(__N__‐methylamino)benzoyloxy]phenyl} 1‐(__N__,__N__‐dimethylamino)diazen‐1‐ium‐1,2‐diolate) generates NO upon